ValuEngine upgraded shares of Welltower (NYSE:HCN) from a hold rating to a buy rating in a research note released on Saturday.
Several other research analysts have also weighed in on HCN. Bank of America lowered shares of Welltower to a neutral rating and lowered their target price for the stock from $78.00 to $77.00 in a research report on Friday, September 22nd. Capital One Financial started coverage on shares of Welltower in a research report on Monday, September 25th. They set an equal weight rating and a $74.00 target price on the stock. UBS Group lowered their target price on shares of Welltower from $71.00 to $69.00 and set a neutral rating on the stock in a research report on Monday, October 2nd. Jefferies Group restated a hold rating and set a $72.00 target price on shares of Welltower in a research report on Tuesday, October 3rd. Finally, Royal Bank of Canada restated a hold rating and set a $74.00 target price on shares of Welltower in a research report on Tuesday, October 10th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of Hold and an average target price of $72.92.
Welltower (HCN) opened at $59.16 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.79. Welltower has a 1 year low of $58.98 and a 1 year high of $78.17. The firm has a market cap of $21,910.31, a PE ratio of 23.85, a price-to-earnings-growth ratio of 3.92 and a beta of 0.25.
In other Welltower news, Director Gary Whitelaw purchased 1,420 shares of the stock in a transaction dated Tuesday, November 21st. The shares were acquired at an average cost of $68.39 per share, for a total transaction of $97,113.80. Following the completion of the transaction, the director now directly owns 1,420 shares of the company’s stock, valued at $97,113.80. The purchase was disclosed in a filing with the SEC, which is available at this link. 0.19% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its position in Welltower by 11.8% during the second quarter. Franklin Resources Inc. now owns 452,545 shares of the real estate investment trust’s stock worth $33,873,000 after acquiring an additional 47,758 shares during the last quarter. Martingale Asset Management L P acquired a new stake in Welltower during the second quarter worth approximately $210,000. Norinchukin Bank The boosted its position in Welltower by 7.9% during the second quarter. Norinchukin Bank The now owns 25,410 shares of the real estate investment trust’s stock worth $1,902,000 after acquiring an additional 1,851 shares during the last quarter. Comerica Securities Inc. boosted its position in Welltower by 6.0% during the second quarter. Comerica Securities Inc. now owns 5,180 shares of the real estate investment trust’s stock worth $388,000 after acquiring an additional 295 shares during the last quarter. Finally, Bahl & Gaynor Inc. boosted its position in Welltower by 3.0% during the second quarter. Bahl & Gaynor Inc. now owns 18,178 shares of the real estate investment trust’s stock worth $1,217,000 after acquiring an additional 533 shares during the last quarter. Institutional investors and hedge funds own 86.46% of the company’s stock.
Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.